Total Payments
$17,192
2021 Payments
$1,594
Companies
35
Transactions
467
Medicare Patients
343
Medicare Billing
$47,904
Payment Breakdown by Category
Food & Beverage$8,504 (49.5%)
Consulting$8,407 (48.9%)
Education$157.50 (0.9%)
Other$122.94 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,504 | 448 | 49.5% |
| Consulting Fee | $8,407 | 5 | 48.9% |
| Education | $157.50 | 8 | 0.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $122.94 | 6 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $8,534 | 15 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $1,047 | 43 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $862.10 | 52 | $0 (2021) |
| Eisai Inc. | $787.92 | 57 | $0 (2020) |
| Adamas Pharmaceuticals, Inc. | $755.20 | 58 | $0 (2021) |
| SK Life Science, Inc. | $503.41 | 19 | $0 (2021) |
| Allergan, Inc. | $482.62 | 46 | $0 (2021) |
| UCB, Inc. | $456.97 | 21 | $0 (2021) |
| GENZYME CORPORATION | $345.40 | 3 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $321.95 | 17 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $1,594 | 92 | SK Life Science, Inc. ($355.20) |
| 2020 | $1,094 | 81 | Allergan, Inc. ($215.98) |
| 2019 | $1,999 | 100 | MacuLogix, Inc. ($256.83) |
| 2018 | $2,165 | 109 | Eisai Inc. ($304.54) |
| 2017 | $10,340 | 85 | PFIZER INC. ($8,464) |
All Payment Transactions
467 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/10/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.69 | General |
| 12/06/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), ONGENTYS | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), ONGENTYS | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $23.35 | General |
| 11/13/2021 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Neurology | ||||||
| 11/10/2021 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 11/05/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), ONGENTYS | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: NEUROLOGY | ||||||
| 11/01/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), ONGENTYS | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: NEUROLOGY | ||||||
| 10/29/2021 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 10/22/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/20/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Neuroscience | ||||||
| 10/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), ONGENTYS | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: NEUROLOGY | ||||||
| 09/20/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), ONGENTYS | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: NEUROLOGY | ||||||
| 09/17/2021 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: PD | ||||||
| 09/17/2021 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $1.64 | General |
| Category: PD | ||||||
| 09/15/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Neuroscience | ||||||
| 09/12/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: PRIMARY CARE | ||||||
| 09/10/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $24.48 | General |
| 08/30/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/16/2021 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: PD | ||||||
| 08/16/2021 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $1.95 | General |
| Category: PD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 170 | 217 | $55,500 | $26,439 |
| 2020 | 5 | 173 | 235 | $58,800 | $21,465 |
Total Patients
343
Total Services
452
Medicare Billing
$47,904
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 79 | $18,170 | $8,689 | 47.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 29 | 29 | $13,080 | $5,942 | 45.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 29 | 34 | $10,200 | $5,348 | 52.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 61 | $9,150 | $4,265 | 46.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $4,900 | $2,195 | 44.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 85 | $19,550 | $6,606 | 33.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 26 | 26 | $11,700 | $4,309 | 36.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 26 | 33 | $9,900 | $3,893 | 39.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 71 | $10,650 | $3,713 | 34.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $7,000 | $2,944 | 42.1% |
About Dr. Michael Siegel, M.D
Dr. Michael Siegel, M.D is a Neurology healthcare provider based in San Mateo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699794115.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Siegel, M.D has received a total of $17,192 in payments from pharmaceutical and medical device companies, with $1,594 received in 2021. These payments were reported across 467 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,504).
As a Medicare-enrolled provider, Siegel has provided services to 343 Medicare beneficiaries, totaling 452 services with total Medicare billing of $47,904. Data is available for 2 years (2020–2021), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location San Mateo, CA
- Active Since 07/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699794115
Products in Payments
- NUPLAZID (Drug) $862.10
- Fycompa (Drug) $787.92
- GOCOVRI (Drug) $755.20
- Briviact (Drug) $335.69
- Aimovig (Biological) $300.31
- COPAXONE (Drug) $296.13
- INGREZZA (Drug) $278.67
- UBRELVY (Drug) $262.37
- AdaptDx (Device) $256.83
- AJOVY (Drug) $243.09
- Xadago (Drug) $242.11
- AUSTEDO (Drug) $234.74
- NUEDEXTA (Drug) $231.72
- AUBAGIO (Drug) $223.36
- EMGALITY (Drug) $175.26
- BOTOX (Biological) $163.55
- Rebif (Biological) $156.30
- MIGRANAL (Drug) $156.02
- GILENYA (Drug) $154.23
- NURTEC ODT (Drug) $152.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.